Swimfins, swim fins, fins or flippers are finlike accessories worn on the foot or leg and made from rubber, plastic or combinations of these materials, to aid movement through the water in water sports activities such as swimming, body boarding, bodysurfing, knee boarding, river boarding, underwater hockey, underwater rugby and various other types of underwater diving.
LPI (LP Information)' newest research report, the “Swim Fins Industry Forecast” looks at past sales and reviews total world Swim Fins sales in 2022, providing a comprehensive analysis by region and market sector of projected Swim Fins sales for 2023 through 2029. With Swim Fins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Swim Fins industry.
This Insight Report provides a comprehensive analysis of the global Swim Fins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Swim Fins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Swim Fins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Swim Fins and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Swim Fins.
The global Swim Fins market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
In United States, Swim Fins key players include Speedo USA, Cressi, FINIS, Aqua Lung International, TYR SPORT, etc. United States top five manufacturers hold a share over 30%. The Midwest is the largest market, with a share over 20%.
In terms of product, Short Blade Swim Fins is the largest segment, with a share over 30%. And in terms of application, the largest application is Entertainment, followed by Training & Fitness.
This report presents a comprehensive overview, market shares, and growth opportunities of Swim Fins market by product type, application, key manufacturers and key regions and countries.
Top Manufactures in Global Swim Fins Includes:
Speedo USA
Cressi
FINIS
Aqua Lung International
TYR SPORT
Arena
Fin Fun
Mares
Beuchat
DMC SWIM
Adolph Kiefer & Associates
Mahina Mermaid
Sun Tail Mermaid
360
H2Odyssey
IST Sports
Market Segment by Type, covers:
Short Blade Swim Fins
Fitness Swim Fins
Monofins
Breaststroke Swim Fins
Other Fins
Market Segment by Applications, can be divided into:
Entertainment
Training & Fitness
Diving
Competition
Others
Key Questions Addressed in this Report
What is the 10-year outlook for the global Swim Fins market?
What factors are driving Swim Fins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swim Fins market opportunities vary by end market size?
How does Swim Fins break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Request Sample Report and Full Report TOC:
https://www.lpinformationdata.com/reports/457158/swim-fins-2029
LP INFORMATION (LPI) is a professional market report publisher based in America, providing high quality market research reports with competitive prices to help decision makers make informed decisions and take strategic actions to achieve excellent outcomes.We have an extensive library of reports on hundreds of technologies.Search for a specific term, or click on an industry to browse our reports by subject. Narrow down your results using our filters or sort by what’s important to you, such as publication date, price, or name.
LP INFORMATION
E-mail: [email protected]
Add: 17890 Castleton St. Suite 369 City of Industry, CA 91748 US
Website: https://www.lpinformationdata.com
This report studies the Swim Fins market, covering market size for segment by type (Short Blade Swim Fins, Fitness Swim Fins, etc.
and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).This report provides detailed historical analysis of global market for Swim Fins from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors.
It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Swim Fins market.Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6509042/global-swim-fins-2021-2030-255Moreover, the impact of COVID-19 is also concerned.
Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase.
In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market.
Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Snorkeling is an activity that is done by swimming on a water body with the help of equipment like a diving mask, swim fins and a shaped breathing tube known as ‘Snorkel’.
The facilities given there by Sea water sports are 100% guaranteed and are at the top of the line.
During snorkeling, one can view the marvels of the submerged world and marine life, particularly in case you are not exceptionally certain of your swimming abilities.
One can also witness few of the rare and exotic coral reefs and colorful fish.
The marine world is far better than the human world.
Dolphin sightseeing and fishing are also excluded from some Snorkeling packages.different water sports have have different packages.
The text above is a summary, you can read full article here.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
